NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced today that it has priced its previously announced underwritten public offering. The company is selling 8,771,930 shares of common stock at $171 per share for expected gross proceeds of approximately $1.5 billion before the underwriting discount and expenses.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.